fura-2-am has been researched along with wortmannin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farndale, RW; Jenner, S; Sage, SO | 1 |
| Hayashi, H; Honjo, H; Ito, S; Katoh, H; Kodama, I; Kume, H; Shimokata, K | 1 |
2 other study(ies) available for fura-2-am and wortmannin
| Article | Year |
|---|---|
Wortmannin inhibits store-mediated calcium entry and protein tyrosine phosphorylation in human platelets.
Topics: Androstadienes; Blood Platelets; Blood Proteins; Calcium; Egtazic Acid; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Humans; In Vitro Techniques; Kinetics; Phosphodiesterase Inhibitors; Phosphoproteins; Phosphorylation; Phosphotyrosine; Terpenes; Thapsigargin; Wortmannin | 1996 |
ML-9, a myosin light chain kinase inhibitor, reduces intracellular Ca2+ concentration in guinea pig trachealis.
Topics: Androstadienes; Animals; Azepines; Calcium; Calcium Channel Blockers; Fura-2; Guinea Pigs; Imidazoles; In Vitro Techniques; Isometric Contraction; Male; Methacholine Chloride; Muscarinic Agonists; Muscle, Smooth; Myosin-Light-Chain Kinase; Potassium; Potassium Channel Blockers; Thapsigargin; Trachea; Wortmannin | 2004 |